Comparative evaluation of antiarrhythmic effects of methacizine and its components during neurogenic atrial fibrillation
Cherednik, I.L.; Sheikh-Zade, I.R.; Galenko-Iaroshevskiĭ, P.A.; Stodolia, G.A.
Biulleten' Eksperimental'noi Biologii i Meditsiny 128(9): 291-293
1999
ISSN/ISBN: 0365-9615 PMID: 10560048 Document Number: 511792
Document emailed within 1 workday
Related Documents
Wu, G.; Jiang, H.; Huang, C.-x.; Yang, B.; Huang, H.; Wang, Y.-l.; Wang, X.-h.; Liu, H.-f.; Yang, X.-h. 2008: Effects of antiarrhythmic drug use on atrial fibrillation recurrence in atrial fibrillation patients post circumferential pulmonary vein ablation Zhonghua Xin Xue Guan Bing Za Zhi 36(7): 623-626Walczak, F.; Szumowski, Łu.; Urbanek, P.; Szufladowicz, E.; Bodalski, R.; Kuśmierczyk, B.; Maryniak, A.; Baranowski, R.ł; Kepski, R.; Bujnowska, E. 2004: Significance of the origin of the right upper pulmonary vein and antiarrhythmic agents in transformation of long-lasting atrial fibrillation to unsustained but repetitive atrial flutter or atrial tachycardia Kardiologia Polska 60(4): 407-414
Popova, E.P. 2005: A comparative study of the effects of antiarrhythmic class III drugs cardiocyclide and sotalol on the atrioventricular fibrillation caused by vagus nerve excitation in narcotized dogs Eksperimental'naia i Klinicheskaia Farmakologiia 68(4): 28-32
Alboni, P.; Gianfranchi, L.; Pacchioni, F.; Pedaci, M. 2005: Antiarrhythmic drugs in patients with recurrent atrial fibrillation: where are we? Italian Heart Journal: Official Journal of the Italian Federation of Cardiology 6(3): 169-174
Galenko-Iaroshevskiĭ, P.A.; Cherednik, I.L.; Sheĭkh-Zade, I.R.; Khankoeva, A.I.; Popov, P.B. 1998: Effect of befol and sufan on the neurogenic atrial fibrillation Biulleten' Eksperimental'noi Biologii i Meditsiny 125(4): 404-406
Fauchier, L.; Pierre, B.; Clementy, N.; Babuty, D. 2013: Non-antiarrhythmic drugs for the prevention of atrial fibrillation: ACEIs, ARBs, statins and PUFAs Le Journal Medical Libanais. Lebanese Medical Journal 61(2): 105-108
Cherednik, I.L.; Sheikh-Zade, I.P.; Galenko-Iaroshevskiĭ, P.A. 1999: Analysis of anti-arrhythmic effect of allapinin during neurogenic atrial fibrillation Biulleten' Eksperimental'noi Biologii i Meditsiny 127(2): 174-176
Kanorskiĭ, S.G.; Zingilevskiĭ, K.B. 2002: Comparative effects of amiodarone, diltiazem, and atenolol on results of electrical cardioversion in patients with chronic atrial fibrillation Kardiologiia 42(8): 44-45
He, R.; Du, X.; Liu, S.W.; Sun, L.J.; Li, Y.; Zeng, H.; Li, Y.Y.; Sun, C.; Zhang, Y.; Ma, C.S.; Gao, W. 2016: Current status of antiarrhythmic drug use and safety assessment in Chinese patients with atrial fibrillation Zhonghua Xin Xue Guan Bing Za Zhi 44(11): 935-939
Cargnelli, G.; Domeneghetti, F.; Ferrari, M.; Malacini, P.; Roberti, G. 1977: Plasma digoxin concentrations in patients with atrial fibrillation and indications for the association with other antiarrhythmic agents International Journal of Clinical Pharmacology and Biopharmacy 15(8): 384-388
Kanorskiĭ, S.G. 2014: Antiarrhythmic therapy in patients with paroxysmal and persistent atrial fibrillation: identification of achievable goals and assessment of available funds Kardiologiia 54(2): 70-74
Cox, J.L.; Schuessler, R.B.; Boineau, J.P. 1991: The surgical treatment of atrial fibrillation. I. Summary of the current concepts of the mechanisms of atrial flutter and atrial fibrillation Journal of Thoracic and Cardiovascular Surgery 101(3): 402-405
Nawada, T.; Tanaka, Y.; Hirai, S.; Hisatome, I.; Hasegawa, J.; Kotake, H.; Mashiba, H. 1994: Evaluation of negative inotropic and antiarrhythmic effects of class 1 antiarrhythmic drugs International Journal of Clinical Pharmacology and Therapeutics 32(7): 347-355
Rondano, E.; Bortnik, M.; Occhetta, E.; Teodori, G.; Caimmi, P.P.; Marino, P. 2013: Evaluation of atrial function after surgical ablation of atrial fibrillation: a Speckle tracking study Minerva Cardioangiologica 61(1): 11-20
Shan, Z.-l.; Wang, Y.-t.; Shi, X.-m.; Yan, J.-j.; Zhou, J.-y.; Guo, J.-p.; Wang, W.-h.; Li, T.-d. 2005: Effects of atrial excitable period on the stability of atrial fibrillation in goats Zhonghua Xin Xue Guan Bing Za Zhi 33(11): 992-994
Steklov, V.I. 2013: Evaluation of risk factors for atrial fibrillation in patients with atrial flutter after radiofrequency ablation of cavotricuspid isthmus Voenno-Meditsinskii Zhurnal 334(2): 30-37
Cox, J.L.; Canavan, T.E.; Schuessler, R.B.; Cain, M.E.; Lindsay, B.D.; Stone, C.; Smith, P.K.; Corr, P.B.; Boineau, J.P. 1991: The surgical treatment of atrial fibrillation. II. Intraoperative electrophysiologic mapping and description of the electrophysiologic basis of atrial flutter and atrial fibrillation Journal of Thoracic and Cardiovascular Surgery 101(3): 406-426
Jazwinska-Tarnawska, E.; Orzechowska-Juzwenko, K.; Niewinski, P.; Rzemislawska, Z.; Loboz-Grudzien, K.; Dmochowska-Perz, M.; Slawin, J. 2001: The influence of CYP2D6 polymorphism on the antiarrhythmic efficacy of propafenone in patients with paroxysmal atrial fibrillation during 3 months propafenone prophylactic treatment International Journal of Clinical Pharmacology and Therapeutics 39(7): 288-292
Ertas, F.; Oylumlu, M.; Akil, M.A.; Acet, H.; Bilik, M.Z.; Celepkolu, T.; Yildiz, A.; Kaya, H.; Alan, S.; Ozhan, H. 2013: Non-valvular atrial fibrillation in the elderly; preliminary results from the National AFTER (Atrial Fibrillation in Turkey: Epidemiologic Registry) Study European Review for Medical and Pharmacological Sciences 17(8): 1012-1016
Wen, S.; Liu, N.; Li, S.; Ning, M.; Kang, J.; Wu, J.; Ruan, Y.; Jiang, C.; Sang, C.; Tang, R.; Long, D.; Yu, R.; Bai, R.; Du, X.; Hu, R.; Dong, J.; Liu, X.; Ma, C. 2015: Predictors of atrial fibrillation recurrence after catheter ablation in hypertrophic cardiomyopathy patients with atrial fibrillation Zhonghua Xin Xue Guan Bing Za Zhi 43(7): 589-594